Protein complex of cyclin B1 and cyclin-dependent protein kinase 1 induces phosphorylation of key substrates that mediate cell cycle transition during the G 2 -M phase. It is believed that cyclin B1 accumulates in the S phase of the cell cycle and reaches the maximal level at mitosis but is absent in G 1 -phase cells. In the present study, we demonstrated that cyclin B1 was expressed in the arrested G 1 -phase MOLT-4 lymphocyte leukemia cells and in G 1 phase T-7 transitional tumor cells, as determined by flow cytometry. In addition, we showed that cyclin B1 was detected in the G 1 phase in breast cancer cells from patient tissues and in lymphocytes from patients with leukemia. These findings were confirmed for the first time by postsorting Western blot analysis and by confocal microscopy. Furthermore, by using postsorting Western blotting, we found that cyclin B1 was expressed in different time-window sections of the G 1 phase under different conditions. For the asynchronously growing T-7 cells, cyclin B1 was detected in early G 1 phase, whereas in MOLT-4 cells arrested in G 1 -S phase, cyclin B1 was mainly detected in late G 1 phase. We propose that the cyclin B1 expressed in the G 1 phase may differ from that expressed in the G 2 -M phase, and that this unscheduled type of cyclin B1 may play an important role in tumorigenesis and apoptosis.
Introduction
The eukaryotic cell cycle consists of the following four discrete phases: G 1 , S, G 2 , and M. Cyclins and the cyclin-dependent protein kinases (CDKs) are two major classes of regulators for cell cycle progression in all eukaryotes (1) (2) (3) . The CDKs are enzymes that phosphorylate other proteins using ATP as the phosphate donor. The role of cyclins is to activate the appropriate CDK at the appropriate time in the cell cycle. Cyclin B1, an important member of cyclin family, is known to form complex with CDK1, which phosphorylates their substrates to urge cells through the G 2 -M phase (4) . Cyclin B1 has been classified in G 2 cyclin because the accumulation of this protein begins at the S phase, essentially restricted to the G 2 -M transition, reaches the maximal level at mitosis, and then is rapidly degraded at metaphase-anaphase transition (4, 5) . Although the scheduled expression mode of cyclin B1 has been reported to be strictly conserved from yeast to mammalian, researchers have reported that cyclin B1 can also be detected in the G 1 phase under certain circumstances. Pines et al. (6) reported that cyclin B1 mRNA and protein in HeLa cells were actually found to be present in G 1 -phase cells after a thymidine-aphidicolin block; however, significant levels of cyclin A or cyclin B1 in the G 1 phase were not detected by immunofluorescence microscopy (7). Gong et al. (8, 9) found that the expression of cyclin B1 could be detected in synchronized cells arrested at the G 1 phase, as determined only by flow cytometry. Viallard et al. (10, 11) also showed that cyclin B1 accumulated at the G 1 phase in human leukemic cell lines. However, cyclin B1 expression in asynchronously growing subgroup cells was not studied at that time because of technique limitations. Besides, they were not able to determine the unscheduled mode of cyclin B1 in G 1 -phase cells or the maximal level of cyclin B1 expression in G 1 -phase cells.
The current study was undertaken to investigate the unscheduled cyclin B1 expression in different human cancer cells. We have established a new method called postsorting Western blotting for the study of unscheduled cyclin B1 expression in asynchronously growing cells. We have confirmed, by using this new method, that the strictly conservative protein cyclin B1 in the G 2 -M phase is expressed in unscheduled mode in the G 1 phase of the cell cycle. We have also demonstrated that cyclin B1 is expressed in different time-window sections of G 1 in the G 1 -phase human tumor cells.
Materials and Methods
Isolation of the Cells from the Cancer Tissues of Patients. We first isolated human breast cancer cells from the breast cancer tissues of patients. For this, 17 fresh breast cancer tissues were placed in RPMI 1640 after being acquired from operation. Fatty, necrotic, and other extraneous tissues were trimmed and minced. The trimmed tissues were filtered through 1-mesh cell sieves and rinsed. Finally, the sieved cells were centrifuged for 10 min at 1000 rpm, and cell pellets were resuspended in 1 ml of culture medium. In addition, lymphocytes were isolated by density gradient centrifugation from the specimens of 15 patients with leukemia. Flow cytometry analysis and cell sorting for the primary human breast cancer cells and lymphocytes were the same as those for the MOLT-4 and the T-7 cell lines, as described below.
Cell Analysis by Flow Cytometry. Cell culture was performed as described previously (12, 13) . Cell synchronization (double thymidine block) was performed as described previously (8) , and cell analysis by flow cytometry was also performed as described previously (12) .
Cell Sorting. Cell sorting was performed by using a FACSVantage (Becton Dickinson, San Jose, CA). G 1 -phase cells were sorted based on DNA diploidy. To sort subgroups in the G 1 phase, the cells were first labeled with cyclin E antibody, and then the labeled cells were sorted in tubes precoated with FCS, containing 0.5 ml of FCS. The sorting windows were selected to include the cells in G 0 , G 1 -early, and G 1 -late phase, respectively, based on the cyclin E expression threshold. Cyclin B1 expression in sorted cell groups was then analyzed by Western blotting and confocal microscopy.
Confocal Fluorescence Microscopy after Sorting. Cell morphological characters sorted in different time-window sections of the G 1 phase were screened using a laser scanning confocal microscope (SPII Confocal System; Leica Microsystems, Inc., Exton, PA).
Postsorting Western Blot Analysis. Cells collected by pipetting were lysed by Laemmli sample buffer [2% SDS, 62 mM Tris, 10% glycerol, 5% ␤-mercaptoethanol, 0.005% bromphenol blue (pH 6.8)]. Samples were boiled for 5 min and then supersonicated. Total cellular proteins from 0.5 ϫ 10 6 cells/sample in each lane were subjected to electrophoresis in 12% polyacrylamide gel. The proteins in the gel were then transferred to polyvinylidene difluoride membrane in mini Vertical Electrophoresis (VE) systems (Amersham-Pharmacia, Piscataway, NJ). After the transfer, the membrane was saturated for 1 h with 5% nonfat dry milk in Tris-buffered saline (pH 7.6), with 0.1% Tween 20. The blots were then incubated with primary mouse antihuman cyclin B1 antibody (diluted to 1:1000), followed by alkaline phosphataseconjugated horse antimouse IgG secondary antibody (Vector Laboratory, Inc., Burlingame, CA) diluted to 1:1000, and the results were detected using enzyme reaction. Molecular weights were determined by comparison to known markers. (Fig. 1A) . However, analysis of cyclin B1 expression in MOLT-4 cells blocked in G 1 -S phase and in T-7-transformed cells revealed that G 1 -phase cells had cyclin B1-positive fluorescence signals (Fig. 1, C and D) . These dot plots indicate that cyclin B1 is expressed in cells residing not only in the G 2 -M phase but also in the G 1 phase of the cell cycle.
Results

Detection of Cyclin
Cyclin B1 Expression in G 1 Phase Cancer Cells Was Confirmed by Confocal Microscopy. Next, we confirmed that cyclin B1 expression occurred in G 1 -phase cells by confocal microscopy (Fig. 2) . The cells sorted in exponentially growing G 1 -phase MOLT-4 cells were used as negative controls ( Fig. 2A) . As can be observed, the fluorescence of cyclin B1 in the G 1 -phase cells is located in the nuclei of both the T-7 cells (Fig. 2B ) and the MOLT-4 cells (Fig. 2C) .
The Time-Window Sections of G 1 When Cyclin B1 Is Differentially Expressed in Synchronized and Asynchronously Growing Tumor Cells. Because the level of cyclin E is consecutively increased during G 1 phase, we used the fluorescence intensity of cyclin E as a marker for different time-window sections of cells in the G 1 phase detected by flow cytometry. All G 1 -phase populations were divided into the following three groups: G 0 , G 1 -early, and G 1 -latephase cells, based on the expression of cyclin E detected by immunofluorescence (Fig. 3, A and C) . Western blot analysis of the three sorted subgroups of the G 1 -phase cells showed that cyclin B1 expression was in G 1 -early phase in asynchronously growing T-7 cells (Fig.  3B) . In contrast, cyclin B1 expression was mainly in G 1 -late phase in synchronized MOLT-4 cells (Fig. 3D) .
Detection of Cyclin B1 Expression in G 1 -Phase Cancer Cells from the Cancer Tissues of Patients. Unscheduled expression of cyclin B1 was also found in human primary cancer cells isolated from patient cancer tissues, as described above. 
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on April 13, 2017. © 2004 American Association for Cancer cancerres.aacrjournals.org Downloaded from 4B shows that cyclin B1 expression was also detected in the G 1 -phase lymphocytes derived from the patients with leukemia. Fig. 4D is a representative result of the Western blot analysis of the sorted G 1 -phase breast cancer cells. As seen, cyclin B1 was expressed in both whole cells and the sorted G 1 -phase cells, suggesting that these in vivo uncontrolled proliferating tumor cells exhibited expression of cyclin B1 not only in the G 2 -M phase but also in the G 1 phase of the cell cycle.
Discussion
It is generally believed that scheduled cyclin B1 is expressed in eukaryotic cells, i.e., synthesized first at late S phase, peaked at G 2 -M phase, and then rapidly degraded by ubiquitin-dependent proteolysis, which was taken for granted to be conservative from yeast to mammalian (1-3) . However, in recent years some studies have shown that cyclin B1 could be detected in some G 1 -phase tumor cell lines (10 -11, 14) . Gong et al. (12) studied the expression of cyclin B1 in MOLT-4 lymphocyte leukemia cells synchronized in the G 1 phase of the cell cycle and found unscheduled expression of cyclin B1 in the G 1 phase in this cancer cell line, as determined by the bivariate analysis (cyclin versus DNA content) of multiparameter flow cytometry. That method allows one to assay the ectopic expression of cell cycle phase-specific protein (12) . Because the DNA content was used to divide the different time-window sections of cells in the cell cycle, the cells in the G 1 phase with the same DNA content could not be divided into any sub-phases. Recently, we noticed that cyclin E is expressed in G 1 -phase cells continuously and reaches peak level over a threshold at the time of entering into the S phase. Therefore, we selected the fluorescence intensity of cyclin E to be the marker (Fig.  3, A and C) as partition of early and late G 1 -phase cells (13) . The expression of cyclin B1 in sorted cells can be assayed by a Western blot analysis. This method, which we call postsorting Western blotting, provides an approach to study more precisely the specific protein(s) for the cell cycles in subpopulations of asynchronously growing cells.
Unscheduled cyclin B1 expression in the G 1 phase also occurs in primary cancer cells from clinical tumor tissues. Besides leukemia and breast cancer cells examined in the present study, we have shown that unscheduled cyclin B1 was expressed in the G 1 phase in other human cancer cells from tumor tissues of patients, including gastric carcinoma, colon cancer, nasopharyngeal carcinoma, and ovarian cancer (data not shown). However, the significance of unscheduled cyclin B1 expression in cancer biology is not clearly defined. Earlier studies reported that the overexpression of cyclins in human tumors was associated with tumor transformation and poor prognosis (15, 16) . Because cyclin B1 normally forms a heterodimeric complex with CDK1 during the G 2 phase resulting in histone kinase activity, which is necessary for the initiation of mitosis, continuous expression of cyclin B1 in tumor cells may allow cyclin B1-CDK1 complex to phosphorylate a series of substrates regardless of the phase in the cell cycle and lead to out of control cell cycle progression. Therefore, the ectopic expression of cyclin B1 in the G 1 phase may be one of the mechanisms of carcinogenesis for some cancer types.
The mechanism accounting for unscheduled expression of cyclin B1 in certain tumor cells is not understood at this time. However, there may exist two possibilities, as follows: (a) the synthesis of cyclin B1 in these cells is not limited to the strict period in the cell cycle, and (b) the proteolytic degradation of this protein is impaired. Therefore, low levels of cyclin B1 can be detected during the G 1 phase of the cell cycle in some tumor cell lines. No matter what reason may lead to the unscheduled expression of cyclin B1, the presence of cyclin B1 in G 1 -phase cells may suggest a possible dysfunction or misregulation of the machinery for cell cycle progression.
The localization of ectopic cyclin B1 expression in G 1 -phase cells is unknown. We show in this report that the restriction period in which cyclin B1 can be detected in the G 1 phase is different under different culture conditions. The ectopic cyclin B1 was expressed in early G 1 phase in asynchronously growing transformed T-7 cells (Fig. 3, A and  B) , whereas in arrested MOLT-4 cells synchronized in the G 1 phase by double thymidine blocking, the ectopic cyclin B1 was mainly detected in late G 1 phase of the cells (Fig. 3D) . Although endogenous cyclin B1 protein has been considered to be one component of M phase-promoting factor, which urges cells through division, the role of ectopic cyclin B1 in the G 1 phase in biological and pathological processes is unclear. We observed recently that when the time for the second thymidine block was increased from 12 to 24 h (or even longer), quite a number of the arrested MOLT-4 cells underwent apoptotic cell death after releasing from block (data not shown), suggesting that this kind of unscheduled cyclin B1, together with CDK1, might be involved in apoptosis under specific circumstances. This hypothesis is supported by some reports showing that the activation of CDK1 was required for apoptosis (17, 18) . Therefore, based on our observations and those of others, we propose that continuous and sustained expression cyclin B1 in the G 1 phase may drive cell cycle progression and lead to uncontrolled cell proliferation, whereas a transient expression of cyclin B1 in the G 1 phase may lead to activation of the apoptosis pathways that cause cell death.
In summary, we showed in this study that cyclin B1 was expressed in the G 1 phase in the synchronized MOLT-4 cells and asynchronously growing T-7 cells, as accessed by flow cytometry. Additionally, cyclin B1 was detected in the G 1 phase in the breast cancer cells from patient tissues and in lymphocytes from the patients with leukemia. Finally, we established a postsorting Western blot technique, and by using this new technique, we demonstrated that cyclin B1 was expressed in early G 1 phase in asynchronously growing T-7 cells and in late G 1 phase in synchronized MOLT-4 cells. Although the role and importance of G 1 -phase cyclin B1 in the tumorigenesis and apoptosis of human malignancy are becoming increasingly apparent, the precise mechanisms of unscheduled expression of cyclin B1 have not been completely understood. Studies are in progress to further investigate the different patterns of unscheduled cyclin B1 expression in different tumor cells and to elucidate the role and mechanism of this protein in cell proliferation and cell death.
